CONCORD BIOTECH LT...● IPO DETAIL◆ GMPNIL◆ STATUSListed◆ IPOCloudTrack Every IPO◆ CONCORD BIOTECH LT...● IPO DETAIL◆ GMPNIL◆ STATUSListed◆ IPOCloudTrack Every IPO◆
Live GMP
Back to IPOs
Concord Biotech Ltd.

Concord Biotech Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹741
₹741
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹741
Based on GMP
Min. Investment
₹14,820
1 lot × 20 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
04 Aug 2023
Close Date
08 Aug 2023
Allotment
11 Aug 2023
Listing Date
18 Aug 2023
Exchange
NSE & BSE
Price Band
₹741
Listing Price
See chart
Allotment Status
Price Band
₹741
Per share
Face Value
₹1 per share
 
Lot Size
20 Shares
per lot
Issue Size
2,09,25,652 shares (aggregating up to ₹1,550.52 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹14,820
1 lot
Post-IPO Holding
10,46,16,204 shares
Promoters
P/E (Pre)
32.29x
 
EPS (Pre)
₹20.79
 
UPI Deadline
2023-08-08
Mandate
Anchor AllotmentThu, 03 Aug 2023
Basis of AllotmentFri, 11 Aug 2023
Refund InitiationMon, 14 Aug 2023
Demat CreditThu, 17 Aug 2023
Listing DayFri, 18 Aug 2023
UPI Mandate Deadline2023-08-08
Sale TypeOffer For Sale
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Concord Biotech Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 08 Aug 2023.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
— — —
NII / HNI
Over 1.00x
— — —
Retail
Over 1.00x
— — —
Total 1.00x
20,925,652
100% ₹1,550.59
IPO Shares Offered
Concord Biotech Ltd. IPO total issue size: ₹1,550.59 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 20,925,652 ₹1,550.59
100.00%
* Based on upper price band ₹741 per share
Lot Size & Investment
Lot Size
20
Shares per Lot
Issue Price
₹741.00
Upper Band
Min Investment
₹14,820
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)240₹29,640
Retail (Max — 13 Lots)13260₹192,660
S-HNI (Min — 14 Lots)14280₹207,480
B-HNI (Min — 68 Lots)681,360₹1,007,760
* Issue Price ₹741 × Lot Size 20 shares
IPO Schedule
Anchor
03 Aug 2023
✓ Done
IPO Open
04 Aug 2023
✓ Done
IPO Close
08 Aug 2023
✓ Done
Allotment
11 Aug 2023
✓ Done
Refunds
14 Aug 2023
✓ Done
Demat Credit
17 Aug 2023
✓ Done
Listing Day
18 Aug 2023
✓ Done
Concord Biotech Ltd. — Live Price LIVE
₹741.00
INR · BSE
Fetching…
vs Issue Price
—
OPEN
—
HIGH
—
LOW
—
MKT CAP
—
P/E
—
52W HIGH
—
52W LOW
—
VOLUME
—
DIVIDEND
—
DIV YIELD
—
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹741.00 Live Price
About Concord Biotech Ltd.
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Concord Biotech Ltd. Financials (Amount in Crore)
Revenue from Operations
₹888.5
31 Mar 2023
₹736.4
31 Mar 2022
₹630.8
31 Mar 2021
Profit After Tax (PAT)
₹240.1
31 Mar 2023
₹174.9
31 Mar 2022
₹234.9
31 Mar 2021
Particulars31 Mar 202131 Mar 202231 Mar 2023
Revenue from Operations 630.75 736.35 888.48
EBITDA N/A N/A N/A
Profit After Tax (PAT) 234.89 174.93 240.08
Net Worth 999.37 1103.22 1290.00
Total Assets 1182.55 1312.80 1513.98
Reserves & Surplus N/A N/A N/A
Borrowings 86.35 60.59 31.24
EBITDA Margin (%) N/A — —
PAT Margin (%) N/A — —
RoE
20.06
RoCE
24.27
RoNW
20
Issue Structure & Shareholding
Total Shares Offered2,09,25,652 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter HoldingN/A
Post-Issue Promoter Holding10,46,16,204 shares
P/BV RatioN/A
RoE20.06
RoCE24.27
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Kotak Mahindra Capital Co.Ltd.
Citigroup Global Markets India Pvt.Ltd.
Jefferies India Pvt.Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Concord Biotech Ltd. IPO subscribed? ▲

Concord Biotech Ltd. IPO is subscribed 1.00 times by Aug 08, 2023. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Concord Biotech Ltd. IPO retail subscription status? ▼

The Concord Biotech Ltd. IPO retail category is subscribed 1.00 times as of 08 Aug 2023. The retail portion is oversubscribed.

How to subscribe Concord Biotech Ltd. IPO? ▼

Subscribe via your broker app using ASBA or UPI. Opens 04 Aug 2023 and closes 08 Aug 2023. Min investment: ₹14,820 (1 lot = 20 shares). UPI mandate: 2023-08-08.

How many times Concord Biotech Ltd. IPO subscribed? ▼

The Concord Biotech Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Concord Biotech Ltd. IPO allotment? ▼

Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 11 Aug 2023. Refunds: on 14 Aug 2023.

When Concord Biotech Ltd. IPO will be listed? ▼

The Concord Biotech Ltd. IPO listing date is 18 Aug 2023, Friday. Listed on: NSE & BSE. Issue price: ₹741. Estimated listing: ₹741. GMP: NIL.

When Concord Biotech Ltd. IPO close? ▼

The Concord Biotech Ltd. IPO closes on 08 Aug 2023, Tuesday. UPI mandate: 2023-08-08. Allotment: 11 Aug 2023. Listing: 18 Aug 2023.